Your session is about to expire
Lomotil vs Imodium
Introduction
For patients experiencing acute or chronic diarrhea, certain drugs that slow the movement of the intestines can help in managing symptoms and reducing discomfort. Lomotil and Imodium are two such medications typically prescribed for this condition. They both work by slowing down intestinal motility, but they do so through different mechanisms of action. Lomotil is a combination medication containing diphenoxylate and atropine; it acts on the smooth muscles in the intestine to decrease bowel movements. Imodium, on the other hand, known as loperamide hydrochloride scientifically, primarily works by decreasing activity of a protein called calmodulin inside cells lining your intestines which results in slower transit time through them.
Lomotil vs Imodium Side By Side
| Attribute | Lomotil | Imodium |
|---|---|---|
| Brand Name | Lomotil | Imodium |
| Contraindications | Clostridium difficile infection, liver disease, obstructive jaundice, severe ulcerative colitis, pseudomembranous colitis caused by antibiotic use. | Clostridium difficile infection, liver disease. |
| Cost | Brand-name: around $150 for 20 tablets. Generic: $1 to $3 per day depending on dosage. | Brand-name: about $10 for 12 caplets. Generic: as low as about $.50 per day to $.75 per day. |
| Generic Name | Diphenoxylate/Atropine | Loperamide |
| Most Serious Side Effect | Extremely fast/irregular heartbeat, severe allergic reactions including fever, swollen lymph nodes, painful sores, rash causing blistering and peeling. | Skin rashes, swelling of face/lips/tongue/throat, difficulty breathing, severe abdominal pain, constipation, fast or irregular heartbeats. |
| Severe Drug Interactions | Not explicitly mentioned, but caution is advised due to its opioid content and potential for abuse. | Not explicitly mentioned, but caution is advised due to potential effects on heart rhythm. |
| Typical Dose | Starts from 2 tablets four times a day, reducing to 1 or 2 tablets three times a day. Maximum 20 mg per day. | Adults: 4 mg initially, then 2 mg after each unformed stool. Maximum 16mg/day. Children's dosing varies by age. |
What is Lomotil?
Diphenoxylate-atropine (the generic name for Lomotil) was one of the first drugs developed from the class of opioid antidiarrheals, which was a significant advancement over previous diarrheal treatments. Diphenoxylate-atropine became approved by the FDA in 1960 and works by slowing down digestion, allowing more time for fluids and electrolytes to be absorbed back into your body. It is prescribed for treating diarrhea. On the other hand, loperamide (Imodium) operates similarly but has less potential for abuse due to its poor penetration of the blood-brain barrier, hence it's available as an over-the-counter medication rather than prescription only like Lomotil. Both medications may provide relief from acute or chronic diarrhea; however, their side effects differ slightly with loperamide generally considered having fewer side effects.
What conditions is Lomotil approved to treat?
Lomotil is approved for the treatment of different types of diarrhea:
- Acute nonspecific diarrhea, which can be caused by a variety of factors such as bacteria, viruses or parasites
- Chronic diarrhea, which is long-term and usually linked to diseases like irritable bowel syndrome (IBS) or Crohn's disease
- Traveler's Diarrhea, often caused by consuming contaminated food or drink
How does Lomotil help with these illnesses?
Lomotil helps to manage diarrhea by slowing the movement of the intestines. It does this through its active ingredient, diphenoxylate, which acts on the smooth muscles of your gastrointestinal tract, reducing their activity and thus slowing down gut motility. Slowing down gut motility allows more time for water and electrolytes to be absorbed from your fecal matter back into your body, resulting in firmer stools that are passed less frequently. Diphenoxylate is an opioid drug with effects similar to morphine but primarily targets the digestive system rather than acting centrally on the brain or spinal cord. Therefore, by decreasing intestinal movements, Lomotil can limit the negative effects of diarrhea and help patients manage their condition and stabilize their bowel movements.
What is Imodium?
Imodium, a brand name for loperamide, is an opioid receptor agonist and acts on the mu-opioid receptors in the myenteric plexus large intestines; it works by slowing down the movement of the gut. This decreases the number of bowel movements and makes the stools less watery. Imodium was first approved by FDA in 1976.
As Imodium is not an anticholinergic drug like Lomotil (Diphenoxylate/Atropine), it does not inhibit acetylcholine's activity at muscarinic receptors. Its lack of action on these receptors means that its side-effect profile also differs from that of drugs like Lomotil - particularly in that it is less likely to cause dry mouth, urinary retention, or blurred vision (common side effects associated with anticholinergics such as Lomotil). The effects on mu-opioid receptors can be beneficial for treating diarrhea, especially in patients who do not respond well to “typical” antidiarrheal drugs such as Diphenoxylate/Atropine.
What conditions is Imodium approved to treat?
Imodium is a well-recognized medication that has received approval for the management of:
- Acute diarrhea, including travelers' diarrhea
- Chronic diarrhea associated with inflammatory bowel disease
- Reducing the volume of discharge from ileostomies (surgical openings in the abdominal wall).
How does Imodium help with these illnesses?
Imodium, also known as loperamide, is a medication that functions by slowing down the movement of bowel contents. This helps in controlling diarrhea symptoms by allowing more water to be absorbed from the fecal matter back into the body, resulting in firmer stools and fewer bowel movements. It primarily acts on opioid receptors present in the gut wall which delay transit time through the intestines. Lomotil, on other hand, combines an anticholinergic agent with a mild opioid to achieve similar effects but may have more side effects such as drowsiness or dry mouth due to its mechanism of action. Imodium does not cross into the brain like most opioids do thus it has less potential for abuse compared to other drugs acting on opioid receptors and is generally considered safer than Lomotil for over-the-counter use.
How effective are both Lomotil and Imodium?
Both diphenoxylate-atropine (Lomotil) and loperamide (Imodium) are effective treatments for diarrhea, gaining FDA approval in 1960 and 1976 respectively. They operate on different mechanisms, so they might be prescribed under varied circumstances. The efficacy of Lomotil and Imodium in managing symptoms of acute or chronic diarrhea was examined in a double-blind clinical trial conducted in 1985; both drugs demonstrated similar effectiveness as well as comparable safety profiles. In this study, all the metrics used to evaluate efficacy against diarrhea showed no notable difference between patients receiving Lomotil or those given Imodium.
A review from 2002 suggested that loperamide is efficient at alleviating signs of diarrhea starting from the first day of treatment with a side effect profile favourable compared to many other antidiarrheal drugs; it's also well tolerated by elderly populations. This research found that loperamide has become one of the most widely prescribed antidiarrheal medication worldwide due to its over-the-counter availability.
A review carried out in 2013 indicated that although diphenoxylate-atropine seems more potent than placebo at treating diarrhoea, it appears similar in efficiency to other common antidiarrheals such as loperamide. Nonetheless, Lomotil is typically considered a second-line treatment option which means it's usually thought about only after an initial course with non-prescription medications like Imodium have been ineffective. Despite being less readily available without prescription compared to Imodium due to its potential for abuse stemming from opioid contents - there remains significant data backing up its use when supervised by medical professionals especially among patients who don't respond adequately to over-the-counter solutions.
Related trials for lomotil and imodium
Find Top Clinical Trials
Choose from over 30,000 active clinical trials.
At what dose is Lomotil typically prescribed?
Oral dosages for Lomotil usually start from 2 tablets four times a day, but studies indicate that reducing the dose to 1 or 2 tablets three times a day may be sufficient for managing diarrhea in most adults. Children should be given an appropriate dosage based on their weight. For both populations, if there is no response after several days, consult your healthcare provider. The maximum dosage of Lomotil that should not be exceeded in any case is 20 mg per day.
At what dose is Imodium typically prescribed?
Imodium therapy, also known as loperamide, is commonly initiated at a dosage of 4 mg (two capsules) for adults followed by 2 mg (one capsule) after each unformed stool. The maximum daily dose should not exceed 16mg/day or eight capsules in any 24-hour period. In children aged two to five years old, the recommended initial single dose is 1 mg three times a day with the daily dose not exceeding 3mg. Between six and eight years old, it's suitable to administer an initial single dose of Imodium of 2mg twice per day but no more than this amount within one full day. For those aged between nine and twelve, an initial single dosage of Imodium can extend up to two milligrams thrice every twenty-four hours without surpassing this limit within that timeframe.
What are the most common side effects for Lomotil?
Common side effects of Lomotil include:
- Dizziness
- Drowsiness (somnolence)
- Dry mouth, nose, or throat
- Nausea
- Vomiting
- Loss of appetite (anorexia)
- Abdominal discomfort or pain
- Skin rash or itching
- Headache
In contrast with Lomotil, Imodium may cause the following side effects:
-Dizziness -Nausea -Tiredness/drowsiness (somnolence) -Dry mouth -Stomach cramps
It's important to note that both medications are used to treat diarrhea and must be used as directed by a medical professional. Contact your healthcare provider if you experience persistent symptoms or severe side effects.
Are there any potential serious side effects for Lomotil?
While both Lomotil and Imodium are widely used to treat diarrhea, they can present some potentially serious side effects in rare cases:
- Allergic reactions: rash, itching/swelling (particularly of the face/tongue/throat), severe dizziness or difficulty breathing.
- Serious stomach/abdominal pain or discomfort
- Unusual tiredness
- Unusual/sudden weight loss
- Mental/mood changes such as confusion or depression.
In very rare cases, usage might lead to an extremely fast/irregular heartbeat.
Additionally, symptoms of a serious allergic reaction may include fever; swollen lymph nodes; painful sores in the mouth or around the eyes; a rash that spreads and causes blistering and peeling.
If any of these symptoms occur when using either Lomotil or Imodium, you should immediately consult with your healthcare provider.
What are the most common side effects for Imodium?
Imodium, also known as loperamide, can have varying side effects including:
- Dry mouth
- Dizziness or drowsiness
- Constipation and stomach cramps
- Nausea, vomiting
- Fatigue or tiredness While severe side effects are less common with Imodium when used at the recommended dosage level, it's important to note that these can potentially include rapid heart rate, fainting, and severe stomach pain. Always consult your physician if you experience persistent adverse symptoms while using this medication.
Are there any potential serious side effects for Imodium?
Even though Imodium is generally safe to use, in some cases it can cause serious side effects. Be aware of the following symptoms:
- Skin rashes, itching or hives
- Swelling of your face, lips, tongue or throat
- Difficulty breathing or swallowing; chest tightness
- Abdominal pain that doesn't go away or gets worse
- Constipation, severe bloating
- Fast or irregular heartbeats (Imodium may affect the rhythm of your heart)
- Unusual drowsiness, tiredness or lethargy
If you notice any of these signs after using Imodium, seek immediate medical attention as they could be indicative of a serious reaction to the medication.
Contraindications for Lomotil and Imodium?
Both Lomotil and Imodium are anti-diarrheal medications, but they can have different side effects on some individuals. If you experience worsening stomach pain or constipation, or notice signs of dehydration such as extreme thirst and decreased urination after taking these drugs, please seek immediate medical attention.
Neither Lomotil nor Imodium should be taken if you've been diagnosed with a certain type of bacterial infection (Clostridium difficile) unless directed by your doctor. Also avoid using these medications if you have liver disease, obstructive jaundice, severe ulcerative colitis or pseudomembranous colitis caused by antibiotic use. Always tell your physician which medications you are currently taking; this includes any other over-the-counter medication to prevent dangerous interactions with both Lomotil and Imodium.
How much do Lomotil and Imodium cost?
For the brand-name versions of these drugs:
- The price for 20 tablets of Lomotil (2.5 mg) averages around $150, which works out to roughly $7-$15/day, depending on your dose.
- The price for a pack of 12 caplets of Imodium (2 mg) is about $10, working out to approximately $0.83/day.
Thus, if you are in the higher dosage range for Lomotil (i.e., up to 20 mg/day), then brand-name Imodium is less expensive on a per-day treatment basis. Please note that cost should not be a primary consideration in determining which of these drugs is right for you.
For generic versions of Lomotil (diphenoxylate/atropine) and Imodium (loperamide), costs can be significantly lower:
- Generic diphenoxylate/atropine comes in packs starting from 20 tablets upwards with approximate costs ranging between $1 and $3 per day depending on your daily dosage.
- Generic loperamide starts from as low as about $.50 per day when buying larger packs upfront and does not typically exceed about $.75 per day even at maximum over-the-counter doses.
Popularity of Lomotil and Imodium
Loperamide, in generic form as well as brand names such as Imodium, was estimated to have been used by about 10 million people in the US in 2020. Loperamide accounted for just over 75% of antidiarrheal drug uses in the US. However, it appears to be one of the most common non-prescription options available for treating acute and chronic diarrhea.
Diphenoxylate/atropine (Lomotil) on the other hand is a prescription medication that has similar functions but also includes an antisecretory agent which may help reduce fluid loss associated with diarrhea. In 2020, Lomotil was prescribed to approximately 1 million individuals accounting for nearly a quarter of all prescriptions written for antidiarrheal drugs during that period. The usage rate of Lomotil has remained relatively steady over recent years indicating its consistent role within diarrhea management strategies.
Conclusion
Both Lomotil (diphenoxylate and atropine) and Imodium (loperamide) are common medications used in the management of acute and chronic diarrhea. They work by slowing down the movement of the gut, which decreases bowel movements. While both drugs have a similar effect on the body, their mechanisms of action differ slightly.
Lomotil works directly on smooth muscle in the intestine to slow it down whereas Imodium primarily acts on opiate receptors located in intestinal wall muscles to reduce gut motility and increase water absorption. In some situations, these medications may be combined for additive effects under careful doctor supervision since they can also interact with each other.
Imodium is considered an over-the-counter medication while Lomotil requires a prescription due to its potential addictive properties if misused or taken off-label. Both drugs are available as generic options, providing cost savings for patients who must pay out-of-pocket expenses.
Patients should anticipate that relief from symptoms may not be immediate with these medications; an adjustment period might be needed before noticeable benefits occur.
In terms of side effects, both drugs are generally well-tolerated but can cause drowsiness or constipation. Because diphenoxylate in Lomotil could potentially lead to drug dependence issues when used improperly or long-term, patients using this medication should closely monitor their usage patterns and seek medical help immediately if they notice any concerning behaviors around use.
Other Trials to Consider
Popular Categories
Popular Guides
Learn More About These Treatments
Refrences
- Worku, S. A., Tadesse, S. A., Abdelwuhab, M., & Asrie, A. B. (2023, June). Antidiarrheal activities of methanolic crude extract and solvent fractions of the root of Verbascum sinaiticum Benth. (Scrophularaceae) in mice. Heliyon. Elsevier BV.http://doi.org/10.1016/j.heliyon.2023.e16386
- Caeiro, J. P., DuPont, H. L., Albrecht, H., & Ericsson, C. D. (1999, June). Oral Rehydration Therapy Plus Loperamide Versus Loperamide Alone in the Treatment of Traveler's Diarrhea. Clinical Infectious Diseases. Oxford University Press (OUP).http://doi.org/10.1086/514786
- Jaffé, G. (1977, May). A Comparison of Lomotil and Imodium in Acute Non-Specific Diarrhoea. Journal of International Medical Research. SAGE Publications.http://doi.org/10.1177/030006057700500309
- Heel, R. C., Brogden, R. N., Speight, T. M., & Avery, G. S. (1978, January). Loperamide. Drugs. Springer Science and Business Media LLC.http://doi.org/10.2165/00003495-197815010-00003
- Akel, T., & Bekheit, S. (2017, November 10). Loperamide cardiotoxicity: “A Brief Review”. Annals of Noninvasive Electrocardiology. Wiley.http://doi.org/10.1111/anec.12505
- Heel, R. C., Brogden, R. N., Speight, T. M., & Avery, G. S. (1978, January). Loperamide. Drugs. Springer Science and Business Media LLC.http://doi.org/10.2165/00003495-197815010-00003
- Ericsson, C. D., & Johnson, P. C. (1990, June). Safety and efficacy of loperamide. The American Journal of Medicine. Elsevier BV.http://doi.org/10.1016/0002-9343(90)90269-j